Jiang Shi

1.0k total citations
25 papers, 753 citations indexed

About

Jiang Shi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiang Shi has authored 25 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiang Shi's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (8 papers). Jiang Shi is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (8 papers). Jiang Shi collaborates with scholars based in China, United States and Canada. Jiang Shi's co-authors include Xiujun Cai, Junjie Xu, Zhongjie Lin, Zhe Wan, Lin Ji, Shunjie Xia, Dong Cen, Xiao Liang, Junhao Zheng and Jiang Chen and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and Molecular Cancer.

In The Last Decade

Jiang Shi

22 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiang Shi China 14 619 446 75 69 50 25 753
Juanni Li China 16 605 1.0× 405 0.9× 112 1.5× 141 2.0× 76 1.5× 39 814
Minhua Rong China 20 777 1.3× 753 1.7× 71 0.9× 76 1.1× 65 1.3× 38 970
Yaliang Lan China 9 360 0.6× 296 0.7× 77 1.0× 55 0.8× 57 1.1× 12 526
Xiqiang Cai China 11 385 0.6× 225 0.5× 154 2.1× 85 1.2× 61 1.2× 14 616
Shunjie Xia China 9 534 0.9× 399 0.9× 86 1.1× 98 1.4× 50 1.0× 13 731
Tianwei Xu China 10 480 0.8× 399 0.9× 72 1.0× 58 0.8× 49 1.0× 16 597
Shengqi Shen China 16 638 1.0× 396 0.9× 116 1.5× 123 1.8× 94 1.9× 23 876
Yanqing Wu China 10 428 0.7× 318 0.7× 111 1.5× 57 0.8× 23 0.5× 16 572
Zhe Yang China 15 407 0.7× 280 0.6× 135 1.8× 101 1.5× 81 1.6× 42 656
Yongqian Shu China 16 658 1.1× 347 0.8× 135 1.8× 88 1.3× 43 0.9× 22 773

Countries citing papers authored by Jiang Shi

Since Specialization
Citations

This map shows the geographic impact of Jiang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Shi more than expected).

Fields of papers citing papers by Jiang Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Shi. The network helps show where Jiang Shi may publish in the future.

Co-authorship network of co-authors of Jiang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Shi. A scholar is included among the top collaborators of Jiang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Shi. Jiang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Cong, et al.. (2024). ETS1 promotes cisplatin resistance of NSCLC cells by promoting GRP78 transcription. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 4633–4643.
3.
Shen, Zefeng, Liye Tao, Yiwei Zhu, et al.. (2024). Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers. Advanced Science. 12(6). e2403040–e2403040. 9 indexed citations
4.
Shi, Jiang, et al.. (2023). Circ_0110498 facilitates the cisplatin resistance of non‐small cell lung cancer by mediating the miR‐1287‐5p/RBBP4 axis. Thoracic Cancer. 14(7). 662–672. 8 indexed citations
5.
Shi, Jiang, et al.. (2023). Regulation of tumorigenesis and ferroptosis in non-small cell lung cancer by a novel BBOX1-AS1/miR-326/PROM2 axis. Molecular and Cellular Biochemistry. 479(8). 2143–2155. 7 indexed citations
6.
Chen, Jiang, Jiang Shi, Bixia Li, et al.. (2022). CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway. Science China Life Sciences. 65(10). 1998–2016. 17 indexed citations
7.
Xu, Qin-Fu, et al.. (2022). Circ_0006006 facilitates non‐small cell lung cancer progression by modulating miR‐924/SRSF7 axis. The Journal of Gene Medicine. 24(5). e3411–e3411. 13 indexed citations
8.
9.
Shi, Jiang, et al.. (2021). KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 148–148. 36 indexed citations
10.
Pan, Yu, Jiang Shi, Shunjie Xia, et al.. (2021). Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 637971–637971.
11.
12.
13.
Xu, Junjie, Zhe Wan, Minyue Tang, et al.. (2020). N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling. Molecular Cancer. 19(1). 163–163. 214 indexed citations
14.
Shi, Jiang, et al.. (2020). MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia. Life Sciences. 255. 117826–117826. 14 indexed citations
15.
Shi, Jiang, et al.. (2020). Ganoderic acid B attenuates LPS-induced lung injury. International Immunopharmacology. 88. 106990–106990. 18 indexed citations
16.
Ji, Lin, Zhongjie Lin, Zhe Wan, et al.. (2020). miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR. Cell Death and Disease. 11(4). 250–250. 69 indexed citations
17.
Lin, Zhongjie, Shunjie Xia, Yuelong Liang, et al.. (2020). LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription. Theranostics. 10(19). 8834–8850. 50 indexed citations
18.
Wang, Huan, Ying Liu, Jiang Shi, & Zhe Cheng. (2019). ORMDL3 knockdown in the lungs alleviates airway inflammation and airway remodeling in asthmatic mice via JNK1/2-MMP-9 pathway. Biochemical and Biophysical Research Communications. 516(3). 739–746. 18 indexed citations
19.
Shi, Jiang, et al.. (2019). Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells. European Journal of Pharmacology. 862. 172615–172615. 49 indexed citations
20.
Chen, Jiang, Tong Ji, Di Wu, et al.. (2019). Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma. Cell Death and Disease. 10(6). 425–425. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juanni Li Breakdown of academic impact, for papers by Minhua Rong Breakdown of academic impact, for papers by Yaliang Lan Breakdown of academic impact, for papers by Xiqiang Cai Breakdown of academic impact, for papers by Shunjie Xia Breakdown of academic impact, for papers by Tianwei Xu Breakdown of academic impact, for papers by Shengqi Shen Breakdown of academic impact, for papers by Yanqing Wu Breakdown of academic impact, for papers by Zhe Yang Breakdown of academic impact, for papers by Yongqian Shu
Rankless by CCL
2026